Clinical Trials Directory

Trials / Terminated

TerminatedNCT05834569

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

The Impact of Intravenous Administration of Perioperative Acetaminophen and Ibuprofen Combination (Maxigesic®) on Postoperative Delirium in Elderly Patients Undergoing Minimally Invasive Lung Segmentectomy or Lobectomy

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Korea University Guro Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this interventional study is to investigate the impact of perioperative administration of Maxigesic (combination of acetaminophen and ibuprofen) on delirium after minimally invasive lung surgery in elderly patients. The Maxigesic group receives a total of 5 doses of Maxigesic (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthesia induction. The control group receives the same volume of normal saline. Researchers compare the incidence and severity of postoperative delirium for 5 days after surgery.

Conditions

Interventions

TypeNameDescription
DRUGAcetaminophen and IbuprofenPatients in the Maxigesic group will be administered a total of 5 doses of the drug (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthetic induction.
DRUGNormal salinePatients in the control group will be administered equal amounts of normal saline at the same time points.

Timeline

Start date
2023-06-15
Primary completion
2025-01-23
Completion
2025-01-23
First posted
2023-04-28
Last updated
2025-09-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05834569. Inclusion in this directory is not an endorsement.